(Q36158746)

English

Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

paroxysmal nocturnal hemoglobinuria

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Elaine M Sloand

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Loretta Pfannes

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Phillip Scheinberg

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Kenneth More

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Colin O Wu

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

McDonald Horne

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Neal S Young

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

26 October 2008

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Experimental Hematology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

36

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1616-1624

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Structure and function of the urokinase receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Natural history of paroxysmal nocturnal hemoglobinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

The effects of complement activation on platelets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 October 2017

Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 July 2018

Activation of the alternate complement pathway by autologous red cell stroma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

2 July 2018

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

23 September 2018

Paroxysmal nocturnal hemoglobinuria: current issues in pathophysiology and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

23 September 2018

Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

23 September 2018

Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

23 September 2018

Plasmatic coagulation and fibrinolytic system alterations in PNH: relation to clone size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

23 September 2018

Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417356

23 September 2018

Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative roles of decay‐accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement‐mediated lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excess soluble urokinase-type plasminogen activator receptor in the plasma of patients with paroxysmal nocturnal hemoglobinuria inhibits cell-associated fibrinolytic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of plasma clots by urokinase-soluble urokinase receptor complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and clinical spectrum of type I plasminogen deficiency: A series of 50 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18954937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.EXPHEM.2008.06.016

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36158746&oldid=1623531973"